Home › Schizophrenia › Florida
Schizophrenia clinical trials in Florida
26 studies for Schizophrenia are looking for participants at sites in Florida.
Cities in Florida
- Hollywood15 studies
- Hialeah13 studies
- Miami10 studies
- West Palm Beach7 studies
- Orlando6 studies
- Tampa4 studies
- Boca Raton3 studies
- Deltona3 studies
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- Local Institution - 0019, Miami
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07101094Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Research Centers of America ( Hollywood ), Hollywood
- Local Institution - 0195, Oakland Park
- Health Synergy Clinical Research, West Palm Beach
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 28, 2026 · NCT07686263NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Atlantis
- Neurocrine Clinical Site, Aventura
- Neurocrine Clinical Site, Hollywood
- and 5 more
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07114874Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Sarkis Clinical Trials, Gainesville
- United Research Institute, Hialeah
- Advanced Research Institute of Miami, Homestead
- and 13 more
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 25, 2026 · NCT06229210Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, Hollywood
- Neurocrine Clinical Site, Maitland
- Neurocrine Clinical Site, Miami
- and 3 more
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07227818NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Hollywood
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07105098A Study of Brenipatide in Adult Participants With Schizophrenia
- Magno Medical Research Group, Cooper City
- NextPhase Research Florida - Hollywood, Hollywood
- Innovative Clinical Research, Lauderhill
- and 5 more
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Sep 22, 2026 · NCT07410507A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0145, Boca Raton
- Local Institution - 0160, Gainesville
- Local Institution - 0164, Gainesville
- and 2 more
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 22, 2026 · NCT07424404A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Bonita Springs
- Neurocrine Clinical Site, Hialeah
- Neurocrine Clinical Site, Miami
- and 3 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- University Clinical Research-DeLand, LLC d/b/a Accel Research Sites - DeLand Clinical Research Unit, DeLand
- Behavioral Clinical Research, Inc., Hollywood
- CenExel Hollywood FL, Hollywood
- and 1 more
RecruitingPhase 1
Ages 18 to 55 · All sexes · Updated Sep 17, 2026 · NCT0773449352-week Open Label Safety-Tolerability Study
- CenExel, Hollywood
- Segal Trials, Miami Lakes
- Health Synergy Clinical Research, West Palm Beach
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 9, 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Local Institution - 0119, Hollywood
- Apg Research, Llc, Orlando
RecruitingPhase 3
Ages 13 to 17 · All sexes · Updated Sep 4, 2026 · NCT07288567A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Research Centers of America ( Hollywood ), Hollywood
- Innovative Clinical Research, Inc., Miami Lakes
RecruitingPhase 1
Ages 18 to 55 · All sexes · Updated Sep 2, 2026 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Hollywood
- Clinical Site, Hollywood
- Clinical Site, Miami
- and 2 more
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Envision Trials LLC, Bonita Springs
- Galiz Research, Hialeah
- Local Institution - 0030, Homestead
- and 7 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07379827Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Miami Lakes
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Aug 14, 2026 · NCT05303064Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- Bioxcel Clinical Research Site, Hialeah
RecruitingPhase 1
Ages 10 to 17 · All sexes · Updated Aug 11, 2026 · NCT05025605Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- Segal Institute for Clinical Research, Miami
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Jul 29, 2026 · NCT07467993Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- Health Synergy Clinical Research, Boynton Beach
- Innovative Clinical Research, Miami Lakes
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 27, 2026 · NCT07363577A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- NeuroBehavioral Hospitals of the Palm Beaches - South, Boynton Beach
- Cenexel RCA, Hollywood
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Jun 23, 2026 · NCT07191483A Study to Evaluate the Effect of KarXT on Urological Safety
- Innovative Clinical Research, Lauderhill
- Health Synergy Clinical Research, West Palm Beach
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Jun 3, 2026 · NCT07221877NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Hollywood
- Neurocrine Clinical Site, Miami Lakes
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Mar 6, 2026 · NCT06963034Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
- University of Miami, Miami
Recruiting
Ages 18 to 65 · All sexes · Updated Jan 23, 2026 · NCT07098169Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, North Miami
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jan 12, 2026 · NCT06961968Study of ALTO-101 in Patients With Schizophrenia
- Site 5060, Hollywood
- Site 5015, Tampa
RecruitingPhase 2
Ages 21 to 55 · All sexes · Updated Dec 26, 2025 · NCT06502964Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Hollywood
- Reviva site, Hollywood
- Reviva site, Miami Lakes
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Dec 19, 2024 · NCT05184335From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.